Furthermore, GLP-1 analogues and DPP-4 inhibitors have been shown to reduce BP (prior to reduction of body weight) in diabetic and non-diabetic patients with hypertension, [2], [8]–[11], [35]. The gene discussed is GLP1R; the disease is hypertensive disorder.